Emergent BioSolutions to Release Second Quarter 2020 Financial Results and Conduct Conference Call on July 30, 2020
16 juil. 2020 06h30 HE
|
Emergent BioSolutions
GAITHERSBURG, Md., July 16, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, July 30, 2020 at 5:00 pm (Eastern Time) to discuss the financial...
Emergent BioSolutions Reports Financial Results for First Quarter 2020
30 avr. 2020 16h08 HE
|
Emergent BioSolutions
Reaffirms full year 2020 financial forecastExecutes multi-faceted response to COVID-19 drawing upon longstanding investments in capabilities to address public health threats, as well as expertise in...
Emergent BioSolutions Reports Financial Results for Fourth Quarter and Full Year 2019
20 févr. 2020 16h31 HE
|
Emergent BioSolutions
GAITHERSBURG, Md., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) reported financial results for the quarter and year ended December 31, 2019. FINANCIAL HIGHLIGHTS (in...
Emergent BioSolutions Reports Financial Results for Third Quarter and Nine Months Ended September 30, 2019
06 nov. 2019 16h05 HE
|
Emergent BioSolutions
Q3 2019 performance above guidance Full year 2019 financial forecast reaffirmed GAITHERSBURG, Md., Nov. 06, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) reported financial...
Emergent BioSolutions Reports Financial Results for Second Quarter and Six Months Ended June 30, 2019
01 août 2019 16h05 HE
|
Emergent BioSolutions
Reaffirms full year 2019 financial forecast and operational goalsProvides Q3 2019 revenue forecast of $245M-$275M GAITHERSBURG, Md., Aug. 01, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc....
Emergent BioSolutions to Release Second Quarter 2019 Financial Results and Conduct a Conference Call on August 1, 2019
18 juil. 2019 06h30 HE
|
Emergent BioSolutions
GAITHERSBURG, Md., July 18, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, August 1, 2019 at 5:00 pm (Eastern Time) to discuss the financial...
Emergent BioSolutions Reports First Quarter 2019 Financial Results
02 mai 2019 16h05 HE
|
Emergent BioSolutions
Reaffirms full year 2019 financial forecast and operational goalsProvides Q2 2019 revenue forecast of $200M-$220M GAITHERSBURG, Md., May 02, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc....
Emergent BioSolutions to Release First Quarter 2019 Financial Results and Conduct a Conference Call on May 2, 2019
18 avr. 2019 07h22 HE
|
Emergent BioSolutions
GAITHERSBURG, Md., April 18, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, May 2, 2019 at 5:00 pm (Eastern Time) to discuss the financial...
Emergent BioSolutions Reports Fourth Quarter and Full Year 2018 Financial Results
21 févr. 2019 16h05 HE
|
Emergent BioSolutions
GAITHERSBURG, Md., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) reported financial results for the quarter and year ended December 31, 2018. FINANCIAL HIGHLIGHTS (in...
Emergent BioSolutions to Release Third Quarter 2018 Financial Results and Conduct a Conference Call on November 1, 2018
11 oct. 2018 06h30 HE
|
Emergent BioSolutions
GAITHERSBURG, Md., Oct. 11, 2018 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) will host a conference call on Thursday, November 1, 2018 at 5:00 pm (Eastern Time) to discuss the...